Delivery Order SPE2DB22D2206-SPE2DB25FDR06

Award Date 10/7/24
Potential Completion Date 10/29/24
Potential Value $39K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,271.84 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4567523126 - LYNPARZA 100 MG TABLET UU 60S. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award is a delivery order valued at $21,039.24 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 100 MG TABLET, a pharmaceutical product. The award has an ultimate completion date of February 27, 2025 and utilizes a firm fixed price pricing type. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET in quantities of 120 per shipment. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order has a ceiling value of $118,261.86 and an ultimate completion date of October 9, 2024. This contract is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award is for the delivery of LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,271.84 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 22, 2025, with a completion date of February 12, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYNPARZA 100 MG TABLET, a pharmaceutical product, with a ceiling value of $10,519.62 and a completion date of April 22, 2025. The contract is a Delivery Order under a Firm Fixed Price contract type. This award does not have a set-aside designation, indicating open competition....
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYNPARZA 150 MG TABLET medication. The contract has a ceiling value of $39,483.48 and a completion date of September 13, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation. AmerisourceBergen's Corporate Office division is the prime contractor for this award,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of May 2, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYNPARZA 100 MG TABLET in a quantity of 60 tablets. The order has a firm fixed price of $5,271.84 and a completion date of May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,774.74 for the supply of LYNPARZA 150 MG TABLET. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 9, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the delivery of Lynparza 150 mg tablets, a prescription medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDR06
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of LYNPARZA 100 MG TABLET. The contract, valued at $39,357.76, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of October 29, 2024 and is a Firm Fixed Price arrangement. This contract award was not set aside for any specific business type.

Generated 1/6/25, 12:30 PM